Search Results - Tony Mok
- Showing 1 - 3 results of 3
-
1
A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America by Chi-Lu Chiang, Chi-Lu Chiang, Ross Andrew Soo, Tony Mok, Pei Jye Voon, Lucksamon Thamlikitkul, Ying Cheng, Hidehito Horinouchi, Byong Chul Cho, Krista Lin Xu, Myung-Ju Ahn
Published in Frontiers in Oncology (2025-10-01)Get full text
Article -
2
High-dose alectinib for RET fusion-positive non-small cell lung cancer in the Blood First Assay Screening Trial by Rafal Dziadziuszko, Nir Peled, Tony Mok, Solange Peters, Santiago Ponce Aix, Jorge Alatorre-Alexander, Brian D. Vicuna, Margaret Maclennan, Vijay Bhagawati-Prasad, Sarah M. Shagan, Erica Schleifman, Thorsten Ruf, Michael S. Mathisen, Shirish M. Gadgeel
Published in Contemporary Oncology (2024-02-01)Get full text
Article -
3
CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB–IIIA NSCLC by Jay M. Lee, MD, Jean-Louis Pujol, MD, PhD, Jun Zhang, MD, PhD, Oleg Leonov, MD, PhD, Masahiro Tsuboi, MD, PhD, Edward S. Kim, MD, MBA, Calvin Ng, MD, Nicolas Moreno-Mata, MD, PhD, Amy Cummings, MD, PhD, Ilhan Hacibekiroglu, MD, Abidin Sehitogullari, MD, Nirmal Veeramachaneni, MD, Cathy Spillane, PhD, Jiawei Duan, PhD, Claudia Bossen, PhD, Alexander Savchenko, MD, PhD, Chiara Lobetti-Bodoni, MD, PhD, Tony Mok, MD, Pilar Garrido, MD
Published in JTO Clinical and Research Reports (2025-08-01)Get full text
Article
